Health

FDA Approves Zepzelca (lurbinectedin) and Atezolizumab (Tecentriq) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

DailyTrendDailyTrend
Oct 7, 2025 - 09:00
 0  1
DUBLIN, Oct. 2, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Zepzelca (lurbinectedin) in combination with atezolizumab (Tecentriq) or...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

How to Protect Your Pets From Pollution

How to Protect Your Pets From Pollution

DailyTrend Oct 7, 2025  0  1

FDA Approves Generic Version of Abortion Pill Mifepristone

FDA Approves Generic Version of Abortion Pill Mifepristone

DailyTrend Oct 3, 2025  0  1

Why Brittle Bones Aren’t Just a Woman’s Problem

Why Brittle Bones Aren’t Just a Woman’s Problem

DailyTrend Oct 5, 2025  0  1

Kennedy’s Ties to Ally Leading Vaccine Lawsuits Raise Ethical Concerns

Kennedy’s Ties to Ally Leading Vaccine Lawsuits Raise E...

DailyTrend Oct 4, 2025  0  1

FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.05% ...

DailyTrend Oct 7, 2025  0  1

How Private Equity Oversees the Ethics of Drug Research

How Private Equity Oversees the Ethics of Drug Research

DailyTrend Oct 5, 2025  0  1